4.7 Article

C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack

S. Coveney et al.

Summary: The study found that inflammatory cytokines IL-6, IL-8, and hsCRP independently predicted one-year recurrent vascular events, with IL-6 and hsCRP also predicting one-year fatality. This suggests that baseline inflammatory cytokines can predict late recurrence and supports the rationale for randomized trials of anti-inflammatory agents for prevention after stroke, indicating targeted therapy to high-risk patients with high baseline inflammation may be beneficial.

INTERNATIONAL JOURNAL OF STROKE (2022)

Review Clinical Neurology

Circulating Interleukin-6 Levels and Incident Ischemic Stroke A Systematic Review and Meta-analysis of Prospective Studies

Andreas Papadopoulos et al.

Summary: A systematic review and meta-analysis of cohort studies found a linear association between higher circulating IL-6 levels and increased risk of incident ischemic stroke in community-dwelling individuals. These results provide further evidence supporting the importance of IL-6 signaling in ischemic stroke.

NEUROLOGY (2022)

Article Clinical Neurology

Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial

Peter Kelly et al.

Summary: CONVINCE is a multi-center international Phase 3 clinical trial investigating the effect of low-dose colchicine on recurrent vascular events in patients with non-severe, non-cardioembolic stroke and TIA. The study will provide high-quality randomized data assessing the efficacy and safety of colchicine anti-inflammatory therapy for secondary prevention after stroke.

EUROPEAN STROKE JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease

Meng Xia et al.

Summary: Colchicine treatment in patients with coronary artery disease shows potential in reducing the risk of future cardiovascular events with no significant impact on cardiovascular mortality, and it is generally well-tolerated in terms of adverse events.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Article Clinical Neurology

Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years

John Joseph McCabe et al.

Summary: The study aimed to determine the association between carotid plaque inflammation detected by F-18-fluorodeoxyglucose (18)FDG-PET and late (5-year) recurrent stroke. Results showed that baseline plaque SUVmax and SCAIL score independently predicted 5-year ipsilateral recurrent stroke. This suggests that plaque inflammation-related (18)FDG uptake could improve identification of recurrent ipsilateral stroke over a 5-year period.

NEUROLOGY (2021)

Review Cardiac & Cardiovascular Systems

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials

Aernoud T. L. Fiolet et al.

Summary: This meta-analysis indicates that low-dose colchicine reduces the risk of major adverse cardiovascular events, myocardial infarction, stroke, and the need for coronary revascularization in patients with coronary disease. There was no difference in all-cause mortality, with fewer cardiovascular deaths but more non-cardiovascular deaths.

EUROPEAN HEART JOURNAL (2021)

Editorial Material Cardiac & Cardiovascular Systems

From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?

Paul M. Ridker

CARDIOVASCULAR RESEARCH (2021)

Review Clinical Neurology

Inflammation and Stroke Risk: A New Target for Prevention

Peter J. Kelly et al.

Summary: Inflammation plays a key role in the pathogenesis of stroke, and anti-inflammatory agents have shown benefits for secondary prevention in patients with coronary disease. By reviewing observational studies and randomized controlled trials, the potential implications of anti-inflammatory therapy on stroke prevention are discussed.

STROKE (2021)

Review Clinical Neurology

Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis

J. J. McCabe et al.

Summary: This study conducted a systematic review and meta-analysis on the association between blood inflammatory markers and the risk of recurrent stroke or major vascular events (MVEs) after stroke. The findings indicated that CRP and fibrinogen were associated with recurrent stroke and MVEs, while IL-6 showed some trends but not statistically significant associations. Substantial methodological heterogeneity among studies was identified, highlighting the need for individual-patient pooled analysis and standardization of methods to determine the prognostic role of blood inflammatory markers.

EUROPEAN STROKE JOURNAL (2021)

Article Public, Environmental & Occupational Health

Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults

Yiping Chen et al.

Lancet Global Health (2020)

Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, General & Internal

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement

Lesley A. Stewart et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Review Clinical Neurology

Lipids and Cerebrovascular Disease Research and Practice

Shadi Yaghi et al.

STROKE (2015)

Article Cardiac & Cardiovascular Systems

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

Stephen Kaptoge et al.

EUROPEAN HEART JOURNAL (2014)

Article Neurosciences

Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in Acute Stroke

Laura J. Gray et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2009)

Article Clinical Neurology

C-reactive protein predicts further ischemic events in transient ischemic attack patients

F. Purroy et al.

ACTA NEUROLOGICA SCANDINAVICA (2007)

Review Medicine, General & Internal

Evaluation of the quality of prognosis studies in systematic reviews

JA Hayden et al.

ANNALS OF INTERNAL MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Inflammation as a risk factor for atrial fibrillation

RJ Aviles et al.

CIRCULATION (2003)

Article Hematology

Inflammation and thrombosis

CT Esmon

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)

Article Cardiac & Cardiovascular Systems

Inflammation and atherosclerosis

P Libby et al.

CIRCULATION (2002)